These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7791387)

  • 61. Home spirometry and asthma severity in children.
    Brouwer AF; Roorda RJ; Brand PL
    Eur Respir J; 2006 Dec; 28(6):1131-7. PubMed ID: 16870659
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Patterns of variation in airflow obstruction and risk of death in clinically stable asthma.
    Bohadana AB; Teculescu DB
    Braz J Med Biol Res; 1985; 18(2):157-62. PubMed ID: 3830282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Compliance with peak expiratory flow monitoring in home management of asthma.
    Côté J; Cartier A; Malo JL; Rouleau M; Boulet LP
    Chest; 1998 Apr; 113(4):968-72. PubMed ID: 9554633
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of pulmonary function tests in the diagnosis of occupational asthma.
    Anees W
    Ann Allergy Asthma Immunol; 2003 May; 90(5 Suppl 2):47-51. PubMed ID: 12772952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Relationship of wheezing to the severity of obstruction in asthma.
    Shim CS; Williams MH
    Arch Intern Med; 1983 May; 143(5):890-2. PubMed ID: 6679232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Monitoring asthma with a Mini-Wright Peak Flow Meter.
    Plymat KR; Bunn CL
    Nurse Pract; 1985 Aug; 10(8):25-7, 47. PubMed ID: 4047526
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serial peak expiratory flow rate monitoring--a useful tool in epidemiological studies on occupational asthma.
    Lee HS
    Ann Acad Med Singap; 1994 Sep; 23(5):725-30. PubMed ID: 7847754
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predicting response to therapy in acute asthma.
    Rodrigo GJ
    Curr Opin Pulm Med; 2009 Jan; 15(1):35-8. PubMed ID: 19077703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
    Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR
    Thorax; 1996 Jul; 51(7):664-9. PubMed ID: 8882070
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Parents' evaluations of wheezing in their children with asthma.
    Lee H; Arroyo A; Rosenfeld W
    Chest; 1996 Jan; 109(1):91-3. PubMed ID: 8549227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Is home peak expiratory flow monitoring effective for controlling asthma symptoms?
    McGrath AM; Gardner DM; McCormack J
    J Clin Pharm Ther; 2001 Oct; 26(5):311-7. PubMed ID: 11679021
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monitoring of peak expiratory flow rates during occupational asthma treatment.
    Siracusa A; Forcina A; Brugnami G; Ranciaro A; Fiordi T; Marabini A
    Med Lav; 1992; 83(2):157-66. PubMed ID: 1630404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of peak expiratory flow rate with speaking time in ED patients presenting with acute exacerbation of asthma.
    Koury TG; Counselman FL; Huff JS; Peebles JS; Kolm P
    Am J Emerg Med; 1998 Oct; 16(6):572-5. PubMed ID: 9786540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is home monitoring of lung function worthwhile for children with asthma?
    Sly PD; Flack F
    Thorax; 2001 Mar; 56(3):164-5. PubMed ID: 11182004
    [No Abstract]   [Full Text] [Related]  

  • 75. Peak flow lability: association with asthma and spirometry in an older cohort.
    Enright PL; Burchette RJ; Peters JA; Lebowitz MD; McDonnell WF; Abbey DE
    Chest; 1997 Oct; 112(4):895-901. PubMed ID: 9377950
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Objective measurements of compliance in asthma treatment.
    Chmelik F; Doughty A
    Ann Allergy; 1994 Dec; 73(6):527-32. PubMed ID: 7998669
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma.
    Leroyer C; Perfetti L; Trudeau C; L'Archevĕque J; Chan-Yeung M; Malo JL
    Am J Respir Crit Care Med; 1998 Sep; 158(3):827-32. PubMed ID: 9731012
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Time required to achieve asthma control in not previously inhaled corticosteroid treated adult patients.
    Ramos Costa Mdo R; de Oliveira MA; Caetano LB; Santoro IL; Godoy Fernandes AL
    J Asthma; 2008 Sep; 45(7):579-82. PubMed ID: 18773330
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of asthma control using patient based measures and peak expiratory flow rate.
    Pinto Pereira LM; Boodoo S; Dindial KA; Hosein A; Seemungal TA; Bekele I
    West Indian Med J; 2009 Jun; 58(3):214-8. PubMed ID: 20043527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.